Last Wednesday, members of SoCalBio gathered at the Westlake Village Inn to network and discuss intellectual property matters relevant to today’s biotech companies. Panelists included David Hankin, CEO of the Alfred Mann Foundation for Scientific Research, AnnaMarie Daniels, Vice President of Mentor Biologics, and Michael Wise, partner in the Intellectual Property Group at Perkins Coie. The panel was moderated by Tracy Williams, CEO and President of Olmstead Williams Communications, a corporate public relations firm that specializes in healthcare, life sciences and professional services sectors.
Discussion ranged from R&D perspectives, IP challenges for start-up companies, large corporation focuses and challenges, and the foreign IP landscape. Panelists fielded audience questions ranging from success and failure stories to the costs of obtaining patents overseas.
The Southern California Biomedical Council (SoCalBio or SCBC) is the trade association of the life-science industry in Greater Los Angeles. The mission of SoCalBio is to represent and promote medical device and biotechnology industry in Los Angeles and Orange Counties as well as adjacent communities in the Inland Empire and Gold Coast.
Discussion ranged from R&D perspectives, IP challenges for start-up companies, large corporation focuses and challenges, and the foreign IP landscape. Panelists fielded audience questions ranging from success and failure stories to the costs of obtaining patents overseas.
The Southern California Biomedical Council (SoCalBio or SCBC) is the trade association of the life-science industry in Greater Los Angeles. The mission of SoCalBio is to represent and promote medical device and biotechnology industry in Los Angeles and Orange Counties as well as adjacent communities in the Inland Empire and Gold Coast.
(L-R) Michael Wise, SoCalBio's Ahmed Enany, Tracy Williams, AnnaMarie Daniels and David Hankin
